Market Cap 257.95M
Revenue (ttm) 0.00
Net Income (ttm) -63.73M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.12
Volume 2,854,900
Avg Vol 1,219,294
Day's Range N/A - N/A
Shares Out 54.19M
Stochastic %K 32%
Beta 1.13
Analysts Strong Sell
Price Target $21.07

Company Profile

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is pz-cel, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based g...

Industry: Biotechnology
Sector: Healthcare
Phone: 646 813 4701
Address:
6555 Carnegie Avenue, 4th Floor, Cleveland, United States
TragicRain
TragicRain Mar. 18 at 7:02 PM
$ABEO - Just buying 100 shares at a time when I can under $5 -
0 · Reply
alexpitti
alexpitti Mar. 18 at 6:47 PM
sometimes these stocks have a little bump in the road and fall. and then some macro issue just exacerbates the selling to no end $DCTH $ABEO $STXS
1 · Reply
Longboardsoul
Longboardsoul Mar. 18 at 4:52 PM
$ABEO hopefully Vish the fish can dig into his pockets and throw some rupees down to buy a couple shares..
2 · Reply
Groggok
Groggok Mar. 18 at 4:52 PM
$ABEO OUTPERFORM - $22 PT
0 · Reply
mcube1820
mcube1820 Mar. 18 at 4:35 PM
$ABEO with cash taken into account, this is selling for less than $1.00 @share
0 · Reply
acm20
acm20 Mar. 18 at 3:37 PM
$ABEO Volume supporting the current push upwards from a low of $4.36 earlier.
0 · Reply
ZacksSCR
ZacksSCR Mar. 18 at 3:12 PM
$ABEO: Momentum Building for Zevaskyn® https://buff.ly/4Hy0wDM
0 · Reply
acm20
acm20 Mar. 18 at 3:10 PM
$ABEO Funds now available to add. Anticipating a dip closer to $4 in the near future imo.
1 · Reply
Cautiousamphybian
Cautiousamphybian Mar. 18 at 2:53 PM
$ABEO Put/call ratio for 20th March triple witching is currently sitting at 0.20 with 32k call contracts due to expire and 6.2k call contracts due to expire. Roughly 14k contracts currently in the money with the rest due to expire worthless meaning the MM's don't have to cover them. 11k contracts sit at $4 which is why there's so much pressure to push the price down before Friday. Once we move past triple witching there's not the same obligation by MM's to keep the price pinned and the price should start to trade on fundamentals. You can verify this information for yourselves on Yahoo finance or many other options reporting sites.
1 · Reply
fatpie68
fatpie68 Mar. 18 at 2:48 PM
I saw the same P/S ratio and right now, FinViz has $ABEO at 41.85 which makes sense because they have so little sales - the denominator will go up once they secure more sales (which is what I'm betting on) and that ratio will come down into the industry average.
1 · Reply
Latest News on ABEO
Abeona Therapeutics Inc. (ABEO) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 12:11 PM EST - 4 months ago

Abeona Therapeutics Inc. (ABEO) Q3 2025 Earnings Call Transcript


Abeona Therapeutics Inc. (ABEO) Q2 2025 Earnings Call Transcript

Aug 19, 2025, 3:25 PM EDT - 7 months ago

Abeona Therapeutics Inc. (ABEO) Q2 2025 Earnings Call Transcript


Abeona Therapeutics Inc. (ABEO) Q1 2025 Earnings Call Transcript

May 16, 2025, 1:37 AM EDT - 10 months ago

Abeona Therapeutics Inc. (ABEO) Q1 2025 Earnings Call Transcript


US FDA approves Abeona's skin disorder therapy

Apr 29, 2025, 6:06 AM EDT - 11 months ago

US FDA approves Abeona's skin disorder therapy


Pz-Cel Has Massive Potential For RDEB Patients

Apr 21, 2025, 10:00 AM EDT - 11 months ago

Pz-Cel Has Massive Potential For RDEB Patients


TragicRain
TragicRain Mar. 18 at 7:02 PM
$ABEO - Just buying 100 shares at a time when I can under $5 -
0 · Reply
alexpitti
alexpitti Mar. 18 at 6:47 PM
sometimes these stocks have a little bump in the road and fall. and then some macro issue just exacerbates the selling to no end $DCTH $ABEO $STXS
1 · Reply
Longboardsoul
Longboardsoul Mar. 18 at 4:52 PM
$ABEO hopefully Vish the fish can dig into his pockets and throw some rupees down to buy a couple shares..
2 · Reply
Groggok
Groggok Mar. 18 at 4:52 PM
$ABEO OUTPERFORM - $22 PT
0 · Reply
mcube1820
mcube1820 Mar. 18 at 4:35 PM
$ABEO with cash taken into account, this is selling for less than $1.00 @share
0 · Reply
acm20
acm20 Mar. 18 at 3:37 PM
$ABEO Volume supporting the current push upwards from a low of $4.36 earlier.
0 · Reply
ZacksSCR
ZacksSCR Mar. 18 at 3:12 PM
$ABEO: Momentum Building for Zevaskyn® https://buff.ly/4Hy0wDM
0 · Reply
acm20
acm20 Mar. 18 at 3:10 PM
$ABEO Funds now available to add. Anticipating a dip closer to $4 in the near future imo.
1 · Reply
Cautiousamphybian
Cautiousamphybian Mar. 18 at 2:53 PM
$ABEO Put/call ratio for 20th March triple witching is currently sitting at 0.20 with 32k call contracts due to expire and 6.2k call contracts due to expire. Roughly 14k contracts currently in the money with the rest due to expire worthless meaning the MM's don't have to cover them. 11k contracts sit at $4 which is why there's so much pressure to push the price down before Friday. Once we move past triple witching there's not the same obligation by MM's to keep the price pinned and the price should start to trade on fundamentals. You can verify this information for yourselves on Yahoo finance or many other options reporting sites.
1 · Reply
fatpie68
fatpie68 Mar. 18 at 2:48 PM
I saw the same P/S ratio and right now, FinViz has $ABEO at 41.85 which makes sense because they have so little sales - the denominator will go up once they secure more sales (which is what I'm betting on) and that ratio will come down into the industry average.
1 · Reply
azv134
azv134 Mar. 18 at 2:45 PM
$ABEO i will double my position if this stock goes down to 4.0… crazyyy cheap now
0 · Reply
alexpitti
alexpitti Mar. 18 at 2:41 PM
$ABEO of course I'm emotional. This is a great technology being manipulated by weird short sellers
0 · Reply
BillyRaven
BillyRaven Mar. 18 at 2:31 PM
$ABEO Abeo is currently doing biopsies and treatments and the share price is 20% lower than it was 6 months ago. And we are 2 weeks away from the 2nd qtr which will be a breakeven quarter at the very least. There is a major disconnect here that will be corrected soon.
1 · Reply
savvy_1
savvy_1 Mar. 18 at 2:16 PM
$ABEO buying here or lower will be profitable down the road. The key is to not be emotional when things go against you. Thesis here is good imo. If you believe in this drug then let it ride and just be patient.
1 · Reply
alexpitti
alexpitti Mar. 18 at 1:55 PM
oppenheimer $22 price target. welcome to biotech. shares can be temporarily manipulated to any price $ABEO
2 · Reply
JimiJoJeeter
JimiJoJeeter Mar. 18 at 1:52 PM
$ABEO Holy bear raid, Batman...
0 · Reply
KoGuy
KoGuy Mar. 18 at 1:45 PM
$ABEO Although everyone says the situation is good, the market does not seem to be taking it that way at all. It is highly likely that market makers will try to drive the stock price down to the $4 level before the March 20 options expiration. This is largely because management appeared to have lost confidence, referring to achieving second-quarter earnings as a "realistic goal" during the earnings announcement. If call option open interest rises to the level of June futures open interest, market makers will apply downward pressure once again. Short sellers will also be able to realize profits on this stock with great ease. This trend will continue until the company proves its profitability. In other words, the stock price will absolutely not rise until August.
2 · Reply
creditgoo
creditgoo Mar. 18 at 1:38 PM
$ABEO tehehe
0 · Reply
fatpie68
fatpie68 Mar. 18 at 12:14 PM
Anyone can research and find the equation for themselves. The Buffett Valuation Equation uses P/E, EPS (ttm) and Growth Rate (I get those from FinViz and Yahoo Finance usually). I check for updated data weekly. $ABEO doesn't have an annual growth rate yet but it does have a next quarter rate - which I'm using and I expect it will change after the next earnings report, but they all do (even with an annual rate).
0 · Reply
fatpie68
fatpie68 Mar. 18 at 9:45 AM
There's a lot to like about $ABEO now that it has a permanent HCPCS J code for #ZEVASKYN - which is covered by all major insurers. Their GMARG improved 843% from Q3 to Q4 2025 with initial sales starting and I expect a sales boom in 2026. The high Short Interest combined with 68+% Institutional Ownership tells me that the fat cats are trying to keep the share price as low as possible so they can gorge themselves on as many cheap shares as possible BEFORE the Revenues & Earnings Rocket takes off. FinViz currently has a TP of $20 and using the Buffett equation, I get a TP of $32 with the latest figures.
1 · Reply
Estimize
Estimize Mar. 18 at 12:10 AM
$ABEO reported -0.30 EPS and 5.20 revenue for Q4. http://www.estimize.com/intro/abeo?chart=historical&metric_name=eps&utm_content=ABEO&utm_
0 · Reply
stockinvestor102
stockinvestor102 Mar. 17 at 10:48 PM
$ABEO I read the q4 2025 earnings call transcript and feel very confident. I get some people are likely frustrated with initial slowness of the launch, but it’s better to get it right than to rush things and have it come back to bite you. As things progress, the process will get faster and more patients will be treated which will be good for Abeona.
1 · Reply